(NASDAQ:ALSAU)
Related Posts
Wolfe Research Initiates Coverage On MeridianLink with Outperform Rating, Announces Price Target of $30
Wolfe Research analyst Darrin Peller initiates coverage on MeridianLink (NYSE:MLNK) with a Outperform rating and announces Price Target of $30.
Khiron Launches First Clinic In Europe With Zerenia Clinics UK To Improve Access To Medical Cannabis
Vertically integrated medical cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced on Wednesday the opening of Zerenia Clinics UK in London as its first International Zerenia clinic in Europe.
